Tratnjek, Larisa
Sibinovska, Nadica
Kralj, Slavko
Makovec, Darko
Kristan, Katja
Kreft, Mateja Erdani
Funding for this research was provided by:
Lek Pharmaceuticals, d.d
Javna Agencija za Raziskovalno Dejavnost RS (P3-0108, P2-0089, P3-0108, P3-0108)
MRIC UL Infrastructure program (IP-0510, IP-0510)
Article History
Received: 21 September 2020
Accepted: 25 February 2021
First Online: 23 March 2021
Competing interests
: The authors declare no competing interests.